| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | menotrophin (Meriofert®) |
| Formulation | 75 IU and 150 IU powder and solvent for solution for injection |
| Reference number | 3631 |
| Indication | For the induction of ovulation in amenorrhoeic or anovulatory women who have not responded to treatment with clomiphene citrate; for controlled ovarian hyperstimulation within a medically assisted reproduction technology: induction of multiple follicular development in women undergoing assisted reproduction techniques such as in vitro fertilization |
| Company | Pharmasure Ltd |
| BNF chapter | Obstetrics, gynaecology & urinary tract disorders |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 13/12/2017 |